Trader consensus on Polymarket reflects a 92% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as a buyer rather than a target. Recent acquisitions—including Bun for Claude Code acceleration in December 2025, Vercept for computer-use capabilities in February 2026, and biotech startup Coefficient Bio for $400 million in April 2026—signal strong independence and diversification into life sciences. Soaring revenue forecasts ($18 billion in 2026, $55 billion in 2027) and IPO exploration further bolster its $300–400 billion valuation, deterring buyers amid antitrust scrutiny on big tech AI consolidations like Amazon and Google's stakes. Realistic challenges include a transformative offer exceeding precedents or regulatory pressures forcing a sale, though financial momentum makes these low-likelihood scenarios.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui$14,758 Vol.
$14,758 Vol.
Dec 31, 2026
$14,758 Vol.
$14,758 Vol.
Dec 31, 2026
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 92% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as a buyer rather than a target. Recent acquisitions—including Bun for Claude Code acceleration in December 2025, Vercept for computer-use capabilities in February 2026, and biotech startup Coefficient Bio for $400 million in April 2026—signal strong independence and diversification into life sciences. Soaring revenue forecasts ($18 billion in 2026, $55 billion in 2027) and IPO exploration further bolster its $300–400 billion valuation, deterring buyers amid antitrust scrutiny on big tech AI consolidations like Amazon and Google's stakes. Realistic challenges include a transformative offer exceeding precedents or regulatory pressures forcing a sale, though financial momentum makes these low-likelihood scenarios.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Pasar Dibuka: Nov 12, 2025, 5:14 PM ET
Volume
$14,758Tanggal Berakhir
Dec 31, 2026Pasar Dibuka
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 92% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as a buyer rather than a target. Recent acquisitions—including Bun for Claude Code acceleration in December 2025, Vercept for computer-use capabilities in February 2026, and biotech startup Coefficient Bio for $400 million in April 2026—signal strong independence and diversification into life sciences. Soaring revenue forecasts ($18 billion in 2026, $55 billion in 2027) and IPO exploration further bolster its $300–400 billion valuation, deterring buyers amid antitrust scrutiny on big tech AI consolidations like Amazon and Google's stakes. Realistic challenges include a transformative offer exceeding precedents or regulatory pressures forcing a sale, though financial momentum makes these low-likelihood scenarios.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Volume
$14,758Tanggal Berakhir
Dec 31, 2026Pasar Dibuka
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects a 92% implied probability against Anthropic being acquired before 2027, driven by the AI lab's aggressive expansion as a buyer rather than a target. Recent acquisitions—including Bun for Claude Code acceleration in December 2025, Vercept for computer-use capabilities in February 2026, and biotech startup Coefficient Bio for $400 million in April 2026—signal strong independence and diversification into life sciences. Soaring revenue forecasts ($18 billion in 2026, $55 billion in 2027) and IPO exploration further bolster its $300–400 billion valuation, deterring buyers amid antitrust scrutiny on big tech AI consolidations like Amazon and Google's stakes. Realistic challenges include a transformative offer exceeding precedents or regulatory pressures forcing a sale, though financial momentum makes these low-likelihood scenarios.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui
Hati-hati dengan link eksternal.
Hati-hati dengan link eksternal.
Pertanyaan yang Sering Diajukan